BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15059110)

  • 21. Cutaneous reaction to naproxen.
    Gonzalo Garijo MA; Bobadilla González P
    Allergol Immunopathol (Madr); 1996; 24(2):89-92. PubMed ID: 8933896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance.
    Andri L; Falagiani P
    Allergol Immunopathol (Madr); 2007; 35(4):126-9. PubMed ID: 17663920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Allergic contact dermatitis caused by etofenamate].
    Degenhardt A; Zick C; Hausen BM
    Z Hautkr; 1988 Jun; 63(6):475-8. PubMed ID: 2970161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exacerbation of inflammatory bowel disease associated with use of celecoxib.
    Bonner GF
    Am J Gastroenterol; 2001 Apr; 96(4):1306-8. PubMed ID: 11316199
    [No Abstract]   [Full Text] [Related]  

  • 25. Psoriasiform fixed drug eruption caused by nimesulide.
    Katoulis AC; Bozi E; Kanelleas A; Makris M; Alevizou A; Panagiotides I; Stavrianeas NG
    Clin Exp Dermatol; 2009 Oct; 34(7):e360-1. PubMed ID: 19486051
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adverse cutaneous reaction to celecoxib: 6 cases].
    Murr D; Bocquet H; Lelouet H; Fischer RM; Revuz J; Cosnes A
    Ann Dermatol Venereol; 2003 May; 130(5):519-21. PubMed ID: 12843828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nephrotic syndrome associated to celecoxib].
    Sirvent AE; Enríquez R; Amorós F; Reyes A
    Nefrologia; 2005; 25(1):81-2. PubMed ID: 15789542
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
    Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective hypersensitivity to nimesulide.
    Viola M; Maietta G; Quaratino D; Rumi G; Gaeta F; Romano A
    Allergy; 2008 May; 63(5):624-6. PubMed ID: 18394140
    [No Abstract]   [Full Text] [Related]  

  • 30. Fixed drug eruption from piroxicam.
    Cuerda Galindo E; Goday Buján JJ; García Silva JM; Martínez W; Verea Hernando M; Fonseca E
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):586-7. PubMed ID: 15324401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
    Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
    Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lower gastrointestinal hemorrhage associated with celecoxib].
    Serrano Pozo A; Jara Palomares L; Fuentes Rodríguez F; Calderón Sandubete E
    An Med Interna; 2003 Sep; 20(9):497. PubMed ID: 14755912
    [No Abstract]   [Full Text] [Related]  

  • 33. Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation.
    Kleinhans M; Linzbach L; Zedlitz S; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2002 Aug; 47(2):100-2. PubMed ID: 12423408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed drug eruption to nimesulide: an exuberant presentation confirmed by patch testing.
    Marques LP; Villarinho ALCF; Melo MDGM; Torre MGS
    An Bras Dermatol; 2018 Jun; 93(3):470-472. PubMed ID: 29924254
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of patch test in fixed drug eruption due to metamizole (Nolotil).
    Dalmau J; Serra-Baldrich E; Roé E; Peramiquel L; Alomar A
    Contact Dermatitis; 2006 Feb; 54(2):127-8. PubMed ID: 16487292
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
    Lammintausta K; Kortekangas-Savolainen O
    Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia.
    Rattray B; Nugent DJ; Young G
    Haemophilia; 2006 Sep; 12(5):514-7. PubMed ID: 16919082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of celecoxib in patients with adverse reactions to nimesulide.
    Liccardi G; D'Amato G; Canonica GW; Lobefalo G; Noschese P; Piccolo A; Salzillo A; Passalacqua G
    Allergy; 2005 May; 60(5):708-9. PubMed ID: 15813826
    [No Abstract]   [Full Text] [Related]  

  • 40. Cutaneous reaction to oral spironolactone with positive patch test.
    Alonso JC; Ortega FJ; Gonzalo MJ; Palla PS
    Contact Dermatitis; 2002 Sep; 47(3):178-9. PubMed ID: 12537001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.